News

Gastroenterology Advisor5h
Cardiovascular Benefit Seen With Tirzepatide in Head-to-Head Trial
SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
NewsNation on MSN6h
Daily weight loss pill sees success in trials: Eli Lilly
Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...
TipRanks on MSN9h
Shandong Boan Biotechnology’s Dulaglutide Injection Approved for Marketing in China
Shandong Boan Biotechnology Company., Limited. Class H ( ($HK:6955) ) has shared an update. Shandong Boan Biotechnology Co., Ltd. has received ...